Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
The Stellantis 2024 roller coaster hit a new low with CEO Carlos Tavares’s abrupt resignation. Here are three areas a new CEO ...
Some panned the billionaire for overspending on Twitter, but the platform is winning him favor with Donald Trump and ...
The $7 billion RIA welcomes a seasoned professional to help scale the business and draw talent across its private-client and ...
Major technology stocks are positioned for a strong year-end rally as artificial intelligence initiatives accelerate and ...
Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...
Fintel reports that on December 3, 2024, Wedbush downgraded their outlook for Cavco Industries (NasdaqGS:CVCO) from ...
A potential Trump administration may ease regulations for self-driving vehicles, accelerating Tesla's progress ...